
SIGA Technologies, Inc. – NASDAQ:SIGA
SIGA Technologies stock price today
SIGA Technologies stock price monthly change
SIGA Technologies stock price quarterly change
SIGA Technologies stock price yearly change
SIGA Technologies key metrics
Market Cap | 420.93M |
Enterprise value | 324.69M |
P/E | 4.93 |
EV/Sales | 1.86 |
EV/EBITDA | 3.09 |
Price/Sales | 2.43 |
Price/Book | 2.49 |
PEG ratio | -0.02 |
EPS | 1.11 |
Revenue | 157.02M |
EBITDA | 97.41M |
Income | 79.26M |
Revenue Q/Q | 205.53% |
Revenue Y/Y | 44.64% |
Profit margin | 49.33% |
Oper. margin | 60.19% |
Gross margin | 81.6% |
EBIT margin | 60.19% |
EBITDA margin | 62.04% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeSIGA Technologies stock price history
SIGA Technologies stock forecast
SIGA Technologies financial statements
Jun 2023 | 5.87M | -2.87M | -48.92% |
---|---|---|---|
Sep 2023 | 9.23M | -393.06K | -4.26% |
Dec 2023 | 116.48M | 72.25M | 62.03% |
Mar 2024 | 25.42M | 10.27M | 40.41% |
2025 | 161.65M | 78.84M | 48.77% |
---|
Analysts Price target
Financials & Ratios estimates
Payout ratio | 87.27% |
---|
2019 | |
---|---|
2020 | |
2021 | |
2022 | 6.14% |
2023 | 8.04% |
Jun 2023 | 146510759 | 22.43M | 15.31% |
---|---|---|---|
Sep 2023 | 158380838 | 34.24M | 21.62% |
Dec 2023 | 254836193 | 57.97M | 22.75% |
Mar 2024 | 243145330 | 78.15M | 32.14% |
Jun 2023 | -3.58M | -21.68K | -35.86M |
---|---|---|---|
Sep 2023 | -5.09M | 0 | 0 |
Dec 2023 | 79.03M | 21.68K | 43.42M |
Mar 2024 | -6.11M | 0 | -158.98K |
SIGA Technologies alternative data
Aug 2023 | 39 |
---|---|
Sep 2023 | 39 |
Oct 2023 | 39 |
Nov 2023 | 39 |
Dec 2023 | 39 |
Jan 2024 | 39 |
Feb 2024 | 39 |
Mar 2024 | 45 |
Apr 2024 | 45 |
May 2024 | 45 |
Jun 2024 | 45 |
Jul 2024 | 45 |
SIGA Technologies other data
Period | Buy | Sel |
---|---|---|
Dec 2021 | 0 | 30000 |
Patent |
---|
Application Filling date: 15 Feb 2017 Issue date: 15 Jul 2021 |
Application Filling date: 29 Dec 2020 Issue date: 13 May 2021 |
Grant Filling date: 24 Jul 2019 Issue date: 2 Mar 2021 |
Grant Filling date: 2 Jan 2020 Issue date: 15 Dec 2020 |
Grant Filling date: 23 Jul 2019 Issue date: 21 Jul 2020 |
Grant Utility: Methods of preparing tecovirimat Filling date: 9 Nov 2018 Issue date: 26 May 2020 |
Application Filling date: 2 Jan 2020 Issue date: 7 May 2020 |
Grant Filling date: 11 Oct 2018 Issue date: 3 Mar 2020 |
Application Filling date: 23 Jul 2019 Issue date: 19 Dec 2019 |
Application Filling date: 24 Jul 2019 Issue date: 14 Nov 2019 |
Quarter | Transcript |
---|---|
Q1 2024 7 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 13 Mar 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 7 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 8 Aug 2023 | Q2 2023 Earnings Call Transcript |
SIGA Technologies: Impressive Net Sales Guidance, FDA Approval, And Cheap
Chimerix: A Confusing Business Strategy Makes It Unconvincing
SIGA Technologies: Unjustified Selloff, Loading The Boat, Best Monkeypox Play
Moderna 2.0: 3 Stocks To Play The Potential Monkeypox Pandemic
SIGA Technologies: Buy Monkeypox
Earnings Preview Roundtable - Part 1 - Tech And Growth
SIGA Technologies: Solid Business With Means To Address Monkeypox Outbreak
SIGA Technologies: There's An Assured Market For A Smallpox Vaccine
SIGA Technologies: Biodefense Pharma Unlocks New Value Abroad For TPOXX
-
What's the price of SIGA Technologies stock today?
One share of SIGA Technologies stock can currently be purchased for approximately $8.75.
-
When is SIGA Technologies's next earnings date?
Unfortunately, SIGA Technologies's (SIGA) next earnings date is currently unknown.
-
Does SIGA Technologies pay dividends?
Yes, SIGA Technologies pays dividends and its trailing 12-month yield is 10.12% with 87% payout ratio. The last SIGA Technologies stock dividend of undefined was paid on 4 Sep 2025.
-
How much money does SIGA Technologies make?
SIGA Technologies has a market capitalization of 420.93M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 26.31% to 139.92M US dollars.
-
What is SIGA Technologies's stock symbol?
SIGA Technologies, Inc. is traded on the NASDAQ under the ticker symbol "SIGA".
-
What is SIGA Technologies's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of SIGA Technologies?
Shares of SIGA Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are SIGA Technologies's key executives?
SIGA Technologies's management team includes the following people:
- Dr. Phillip Louis Gomez III, M.D., Ph.D. Chief Executive Officer & Director(age: 58, pay: $1,640,000)
- Dr. Dennis E. Hruby Executive Vice President & Chief Scientific Officer(age: 73, pay: $1,470,000)
- Mr. Daniel J. Luckshire Executive Vice President, Chief Financial Officer & Sec.(age: 54, pay: $1,270,000)
- Ms. Robin E. Abrams Gen. Counsel & Chief Admin. Officer(age: 61, pay: $1,100,000)
-
How many employees does SIGA Technologies have?
As Jul 2024, SIGA Technologies employs 45 workers.
-
When SIGA Technologies went public?
SIGA Technologies, Inc. is publicly traded company for more then 27 years since IPO on 10 Sep 1997.
-
What is SIGA Technologies's official website?
The official website for SIGA Technologies is siga.com.
-
Where are SIGA Technologies's headquarters?
SIGA Technologies is headquartered at 31 East 62nd Street, New York, NY.
-
How can i contact SIGA Technologies?
SIGA Technologies's mailing address is 31 East 62nd Street, New York, NY and company can be reached via phone at +212 6729100.
SIGA Technologies company profile:

SIGA Technologies, Inc.
siga.comNASDAQ
45
Drug Manufacturers - Specialty & Generic
Healthcare
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
New York, NY 10065
CIK: 0001010086
ISIN: US8269171067
CUSIP: 826917106